Correlation Between Vericel Corp and NLS Pharmaceutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Vericel Corp and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and NLS Pharmaceutics.

Diversification Opportunities for Vericel Corp and NLS Pharmaceutics

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Vericel and NLS is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Vericel Corp i.e., Vericel Corp and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between Vericel Corp and NLS Pharmaceutics

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.31 times more return on investment than NLS Pharmaceutics. However, Vericel Corp Ord is 3.2 times less risky than NLS Pharmaceutics. It trades about -0.01 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.06 per unit of risk. If you would invest  4,389  in Vericel Corp Ord on January 7, 2025 and sell it today you would lose (399.00) from holding Vericel Corp Ord or give up 9.09% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  NLS Pharmaceutics AG

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vericel Corp Ord has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in May 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
NLS Pharmaceutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NLS Pharmaceutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in May 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Vericel Corp and NLS Pharmaceutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and NLS Pharmaceutics

The main advantage of trading using opposite Vericel Corp and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.
The idea behind Vericel Corp Ord and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon